Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Bouillon

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Anesthesiology|January 24, 2004
Mixed-effects modeling of the intrinsic ventilatory depressant potency of propofol in the non-steady stateThomas Bouillon, Joergen Bruhn, Lucian Radu-Radulescu, et al.
Anesthesiology|March 31, 2006
The well-being model: a new drug interaction model for positive and negative effectsEleonora Zanderigo, Valentina Sartori, Gorazd Sveticic, et al.
Pharmaceutics|October 23, 2021
Model-Informed Precision Dosing during Infliximab Induction Therapy Reduces Variability in Exposure and Endoscopic Improvement between Patients with Ulcerative ColitisRuben Faelens, Zhigang Wang, Thomas Bouillon, et al.
Anesthesia and Analgesia|November 23, 2005
Compartmental pharmacokinetics of dantrolene in adults: do malignant hyperthermia association dosing guidelines work?Tobias Podranski, Thomas Bouillon, Peter M Schumacher, et al.
Anesthesiology|September 26, 2003
A model of the ventilatory depressant potency of remifentanil in the non-steady stateThomas Bouillon, Joergen Bruhn, Lucian Radu-Radulescu, et al.
British Journal of Clinical Pharmacology|January 12, 2019
Optimising infliximab induction dosing for patients with ulcerative colitisErwin Dreesen, Ruben Faelens, Gert Van Assche, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 22, 2020
Apixaban in patients on haemodialysis: a single-dose pharmacokinetics studyInes Van den Bosch, Thomas Bouillon, Peter Verhamme, et al.
Inflammatory Bowel Diseases|August 3, 2019
A Population Pharmacokinetic and Exposure-Response Model of Golimumab for Targeting Endoscopic Remission in Patients With Ulcerative ColitisErwin Dreesen, Wannee Kantasiripitak, Iris Detrez, et al.
Anesthesiology|August 27, 2004
A new closed-loop control system for isoflurane using bispectral index outperforms manual controlStephan Locher, Konrad S Stadler, Thomas Boehlen, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2019
Detection of Drug-Induced Cholestasis Potential in Sandwich-Cultured Human HepatocytesNeel Deferm, Lysiane Richert, Pieter Van Brantegem, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Anesthesiology|January 24, 2004
Mixed-effects modeling of the intrinsic ventilatory depressant potency of propofol in the non-steady stateThomas Bouillon, Joergen Bruhn, Lucian Radu-Radulescu, et al.
Anesthesiology|March 31, 2006
The well-being model: a new drug interaction model for positive and negative effectsEleonora Zanderigo, Valentina Sartori, Gorazd Sveticic, et al.
Pharmaceutics|October 23, 2021
Model-Informed Precision Dosing during Infliximab Induction Therapy Reduces Variability in Exposure and Endoscopic Improvement between Patients with Ulcerative ColitisRuben Faelens, Zhigang Wang, Thomas Bouillon, et al.
Anesthesia and Analgesia|November 23, 2005
Compartmental pharmacokinetics of dantrolene in adults: do malignant hyperthermia association dosing guidelines work?Tobias Podranski, Thomas Bouillon, Peter M Schumacher, et al.
Anesthesiology|September 26, 2003
A model of the ventilatory depressant potency of remifentanil in the non-steady stateThomas Bouillon, Joergen Bruhn, Lucian Radu-Radulescu, et al.
British Journal of Clinical Pharmacology|January 12, 2019
Optimising infliximab induction dosing for patients with ulcerative colitisErwin Dreesen, Ruben Faelens, Gert Van Assche, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 22, 2020
Apixaban in patients on haemodialysis: a single-dose pharmacokinetics studyInes Van den Bosch, Thomas Bouillon, Peter Verhamme, et al.
Inflammatory Bowel Diseases|August 3, 2019
A Population Pharmacokinetic and Exposure-Response Model of Golimumab for Targeting Endoscopic Remission in Patients With Ulcerative ColitisErwin Dreesen, Wannee Kantasiripitak, Iris Detrez, et al.
Anesthesiology|August 27, 2004
A new closed-loop control system for isoflurane using bispectral index outperforms manual controlStephan Locher, Konrad S Stadler, Thomas Boehlen, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2019
Detection of Drug-Induced Cholestasis Potential in Sandwich-Cultured Human HepatocytesNeel Deferm, Lysiane Richert, Pieter Van Brantegem, et al.
Pageof 3